NO20082719L - Aryl-isoksazol-4-yl-oksadiazolderivater - Google Patents
Aryl-isoksazol-4-yl-oksadiazolderivaterInfo
- Publication number
- NO20082719L NO20082719L NO20082719A NO20082719A NO20082719L NO 20082719 L NO20082719 L NO 20082719L NO 20082719 A NO20082719 A NO 20082719A NO 20082719 A NO20082719 A NO 20082719A NO 20082719 L NO20082719 L NO 20082719L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- halogen
- heteroaryl
- heterocyclyl
- optionally substituted
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 15
- 229910052736 halogen Inorganic materials 0.000 abstract 7
- 150000002367 halogens Chemical class 0.000 abstract 7
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 229910003827 NRaRb Inorganic materials 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- FUANEJXWKWHPEA-UHFFFAOYSA-N 4-(1,2-oxazol-4-yl)oxadiazole Chemical class C1=NOC=C1C1=CON=N1 FUANEJXWKWHPEA-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 239000002475 cognitive enhancer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Foreliggende oppfinnelse angår isoksazol-4-yl-oksadiazolderivater med formel I hvor R1 er hydrogen, halogen, aryl, heterocyklyl, heteroaryl, cyano, lavere alkyl, -(CH2)n-cykloalkyl, -(CH2)n-N(R)2, -(CH2)n-O-lavere alkyl eller -(CH2)n-OH; n er 0, 1 e ller 2 R er hydrogen eller lavere alkyl; R2 er cykloalkyl, aryl, heteroaryl eller heterocyklyl, som eventuelt er substituert med én eller flere substituenter, valgt fra gruppen bestående av halogen, cyano, nitro, lavere alkyl, lavere alkoksy, lavere alkoksy substituert med halogen, lavere alkyl substituert med halogen, C(O)O-lavere alkyl, lavere alkylsulfonyl, -NRaRb, -C(O)-NRaRb, -C(O)-heterocyklyl, benzyloksy, heterocyklyl eventuelt substituert med hydroksy, halogen eller lavere alkyl eller er heteroaryl eventuelt substituert med lavere alkyl; Ra og Rb er uavhengig hydrogen, lavere alkylsulfonyl, -C(O)H, -(CH2)n-N(R)2, -(CH2)n-O-lavere alkyl, -(CH2)n-S-lavere alkyl, -(CH2)n-S(O)2-lavere alkyl, heteroarylsulfonyl, lavere alkyl, -(CH2)n-heterocyklyl, eventuelt substituert med lavere alkyl eller er -(CH2)n-cykloalkyl, -(CH2)n-heteroaryl, -(CH2)n-OH, -(CO)-R', hvor R' er lavere alkyl, cykloalkyl eller heteroaryl; R3 er aryl eller heteroaryl, som eventuelt er substituert med halogen eller lavere alkyl substituert med halogen; så vel som farmasøytisk akseptable syreaddisjonssalter derav. Det er funnet at denne klasse forbindelser viser høy affinitet og selektivitet for GABA A ?5 reseptor bindingsseter og might være anvendelige som kognitiv enhancer eller for behandling av kognitive lidelser like Alzheimer's sykdom.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05112956 | 2005-12-23 | ||
| PCT/EP2006/069625 WO2007071598A1 (en) | 2005-12-23 | 2006-12-13 | Aryl-isoxazolo-4-yl-oxadiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082719L true NO20082719L (no) | 2008-09-16 |
Family
ID=37891460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082719A NO20082719L (no) | 2005-12-23 | 2008-06-13 | Aryl-isoksazol-4-yl-oksadiazolderivater |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7541372B2 (no) |
| EP (1) | EP1968972B1 (no) |
| JP (1) | JP5015172B2 (no) |
| KR (1) | KR101121240B1 (no) |
| CN (1) | CN101346372B (no) |
| AR (1) | AR058719A1 (no) |
| AU (1) | AU2006328602B2 (no) |
| BR (1) | BRPI0620146A2 (no) |
| CA (1) | CA2633425A1 (no) |
| ES (1) | ES2397401T3 (no) |
| IL (1) | IL192092A0 (no) |
| NO (1) | NO20082719L (no) |
| RU (1) | RU2426731C2 (no) |
| TW (1) | TWI324602B (no) |
| WO (1) | WO2007071598A1 (no) |
| ZA (1) | ZA200805411B (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007074078A2 (en) * | 2005-12-27 | 2007-07-05 | F. Hoffmann-La Roche Ag | Aryl-isoxazol-4-yl-imidazole derivatives |
| US8492378B2 (en) | 2006-08-03 | 2013-07-23 | Takeda Pharmaceutical Company Limited | GSK-3β inhibitor |
| US8338437B2 (en) * | 2007-02-28 | 2012-12-25 | Methylgene Inc. | Amines as small molecule inhibitors |
| FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
| JP5301557B2 (ja) | 2007-12-04 | 2013-09-25 | エフ．ホフマン−ラ ロシュ アーゲー | イソオキサゾロ−ピリジン誘導体 |
| AU2009258242B2 (en) | 2008-05-14 | 2015-07-16 | The Scripps Research Institute | Novel modulators of sphingosine phosphate receptors |
| TW201033201A (en) * | 2009-02-19 | 2010-09-16 | Hoffmann La Roche | Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
| WO2010126002A1 (ja) * | 2009-04-28 | 2010-11-04 | 塩野義製薬株式会社 | ヘテロ環スルホンアミド化合物を含有する医薬 |
| JP2012180281A (ja) * | 2009-06-29 | 2012-09-20 | Dainippon Sumitomo Pharma Co Ltd | 新規オキサジアゾール誘導体 |
| JP5883034B2 (ja) * | 2011-01-28 | 2016-03-09 | ４エスツェー ディスカバリー ゲゼルシャフト ミット ベシュレンクテル ハフツング | 自己免疫性炎症の治療のためのＩＬ１７及びＩＦＮ−γ阻害 |
| ME02107B (me) * | 2011-09-19 | 2015-10-20 | Heteroaril jedinjenja kao ligandi 5-ht4 receptora | |
| US8604062B2 (en) | 2011-10-20 | 2013-12-10 | Hoffman-La Roche Inc. | Process for the preparation of isoxazolyl-methoxy nicotinic acids |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| US9206160B2 (en) | 2012-06-26 | 2015-12-08 | Saniona Aps | Phenyl triazole derivative and its use for modulating the GABAA receptor complex |
| WO2014001280A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| WO2014001278A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| WO2014001279A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| AU2013283488A1 (en) | 2012-06-26 | 2015-01-15 | Saniona Aps | A phenyl triazole derivative and its use for modulating the GABAA receptor complex |
| WO2017007755A1 (en) | 2015-07-06 | 2017-01-12 | Rodin Therapeutics, Inc. | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase |
| LT3319959T (lt) | 2015-07-06 | 2021-12-27 | Alkermes, Inc. | Histono deacetilazės hetero-halogeno inhibitoriai |
| US10793567B2 (en) | 2017-01-11 | 2020-10-06 | Rodin Therapeutics, Inc. | Bicyclic inhibitors of histone deacetylase |
| IL271149B2 (en) | 2017-06-14 | 2024-05-01 | Trevena Inc | Compounds for modulating s1p1 activity and methods of using the same |
| EA039417B1 (ru) | 2017-08-07 | 2022-01-25 | Родин Терапеутикс, Инк. | Бициклические ингибиторы гистондеацетилазы |
| MX2020006587A (es) | 2017-12-22 | 2020-12-10 | Ravenna Pharmaceuticals Inc | Derivados de aminopiridina como inhibidores de fosfatidilinositol fosfato cinasa. |
| BR102019014802A2 (pt) | 2018-07-20 | 2020-02-04 | Boehringer Ingelheim Int | difluorometil-fenil triazóis |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| WO2021101854A1 (en) | 2019-11-19 | 2021-05-27 | Trevena, Inc. | Compounds and methods of preparing compounds s1p1 modulators |
| KR20220154208A (ko) * | 2020-03-17 | 2022-11-21 | 스미토모 파마 가부시키가이샤 | 옥사디아졸 유도체 |
| US20230183215A1 (en) * | 2020-05-21 | 2023-06-15 | Stemsynergy Therapeutics, Inc. | Notch Inhibitors and Uses Thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9808663D0 (en) * | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic agents |
| US6660753B2 (en) * | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| IT1314191B1 (it) | 1999-10-18 | 2002-12-06 | Recordati Chem Pharm | Derivati isossazolcarbossamidici |
| PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
| GB0108475D0 (en) | 2001-04-04 | 2001-05-23 | Merck Sharp & Dohme | New compounds |
| JP2004536104A (ja) | 2001-07-05 | 2004-12-02 | シナプティック・ファーマスーティカル・コーポレーション | Ｍｃｈ選択的アンタゴニストとしての置換されたアニリン−ピペリジン誘導体 |
| GB0128160D0 (en) * | 2001-11-23 | 2002-01-16 | Merck Sharp & Dohme | Novel compounds |
| WO2005123672A2 (en) | 2004-06-14 | 2005-12-29 | Takeda San Diego, Inc. | Kinase inhibitors |
| EP1812427A4 (en) * | 2004-10-15 | 2009-10-14 | Scripps Research Inst | FATTY ACID AMIDE HYDROLASE OXADIAZOLE KETONE INHIBITORS |
| US20070060589A1 (en) * | 2004-12-21 | 2007-03-15 | Purandare Ashok V | Inhibitors of protein arginine methyl transferases |
-
2006
- 2006-12-13 CN CN2006800486672A patent/CN101346372B/zh not_active Expired - Fee Related
- 2006-12-13 ES ES06841339T patent/ES2397401T3/es active Active
- 2006-12-13 BR BRPI0620146-6A patent/BRPI0620146A2/pt not_active IP Right Cessation
- 2006-12-13 WO PCT/EP2006/069625 patent/WO2007071598A1/en not_active Ceased
- 2006-12-13 KR KR1020087017952A patent/KR101121240B1/ko not_active Expired - Fee Related
- 2006-12-13 CA CA002633425A patent/CA2633425A1/en not_active Abandoned
- 2006-12-13 AU AU2006328602A patent/AU2006328602B2/en not_active Ceased
- 2006-12-13 RU RU2008124198/04A patent/RU2426731C2/ru not_active IP Right Cessation
- 2006-12-13 JP JP2008546382A patent/JP5015172B2/ja not_active Expired - Fee Related
- 2006-12-13 EP EP06841339A patent/EP1968972B1/en not_active Not-in-force
- 2006-12-15 US US11/639,695 patent/US7541372B2/en not_active Expired - Fee Related
- 2006-12-19 TW TW095147562A patent/TWI324602B/zh active
- 2006-12-21 AR ARP060105698A patent/AR058719A1/es not_active Application Discontinuation
-
2008
- 2008-06-12 IL IL192092A patent/IL192092A0/en unknown
- 2008-06-13 NO NO20082719A patent/NO20082719L/no not_active Application Discontinuation
- 2008-06-20 ZA ZA200805411A patent/ZA200805411B/xx unknown
-
2009
- 2009-04-13 US US12/422,317 patent/US7956074B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007071598A1 (en) | 2007-06-28 |
| EP1968972A1 (en) | 2008-09-17 |
| CN101346372A (zh) | 2009-01-14 |
| JP5015172B2 (ja) | 2012-08-29 |
| TWI324602B (en) | 2010-05-11 |
| US7541372B2 (en) | 2009-06-02 |
| KR101121240B1 (ko) | 2012-06-12 |
| TW200732329A (en) | 2007-09-01 |
| RU2008124198A (ru) | 2010-01-27 |
| AU2006328602A1 (en) | 2007-06-28 |
| US20070161686A1 (en) | 2007-07-12 |
| CN101346372B (zh) | 2011-09-28 |
| KR20080080213A (ko) | 2008-09-02 |
| ZA200805411B (en) | 2009-07-29 |
| AU2006328602B2 (en) | 2012-05-31 |
| US20090197875A1 (en) | 2009-08-06 |
| EP1968972B1 (en) | 2012-11-28 |
| BRPI0620146A2 (pt) | 2011-11-01 |
| CA2633425A1 (en) | 2007-06-28 |
| JP2009520751A (ja) | 2009-05-28 |
| AR058719A1 (es) | 2008-02-20 |
| ES2397401T3 (es) | 2013-03-06 |
| US7956074B2 (en) | 2011-06-07 |
| IL192092A0 (en) | 2008-12-29 |
| RU2426731C2 (ru) | 2011-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082719L (no) | Aryl-isoksazol-4-yl-oksadiazolderivater | |
| KR102030305B1 (ko) | 키나제 억제제로서 유용한 인돌 카르복스아미드 화합물 | |
| KR101891494B1 (ko) | 신규 화합물 | |
| ES2401679T3 (es) | Derivados de 6-1H-imidazo-quinazolina y de quinolinas, nuevos inhibidores de MAO y ligandos del receptor de imidazolina | |
| MX2007014403A (es) | Derivados de fenil-3-{(3-(1h-pirrol-2-il)-[1,2,4]oxadiazol-5-il]pi peridin-1-il}-metanona y compuestos relacionados como moduladores aloestericos positivos de los receptores de glutamato metabotropicos. | |
| ATE438632T1 (de) | Aryl-4-ethinylisoxazolderivate | |
| NO20082748L (no) | Aryl-isoksazol-4-yl-imidazo[1, 5-a]pyridinderivater | |
| CY1109724T1 (el) | Θειαδιαζολιδινονες ως αναστολεις gsk-3 | |
| IL189762A0 (en) | Isoxazolo derivatives as gaba a alpha5 inverse agonists | |
| PT2029529E (pt) | Pirrolidinonas substituídas como inibidores de 11 betahidroxiesteróide desidrogenase | |
| NO20082747L (no) | Arylisoksazol-4-yl-imidazolderivater | |
| MY136959A (en) | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof | |
| TW200736257A (en) | Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives | |
| JPWO2008120725A1 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
| KR20100016332A (ko) | 신규한 디벤질아민 구조를 갖는 피리미딘 화합물 및 이것을 함유하는 의약 | |
| JP2018522047A (ja) | Ｒｏｒガンマモジュレータとしての新規化合物 | |
| TW201702226A (zh) | 尿素衍生物或其醫藥上可接受鹽 | |
| JP5129138B2 (ja) | 新規なベンジル（ピリジルメチル）アミン構造を有するピリミジン化合物及びこれを含有する医薬 | |
| JP6434528B2 (ja) | 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用 | |
| WO2007054444A3 (en) | 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives | |
| WO2006041985A3 (en) | Thienopyridinone compounds and methods of treatment | |
| CA2982824C (en) | Oxindole compounds and pharmaceutical compositions thereof | |
| WO2010004198A2 (fr) | Derives anticancereux, leur preparation et leur application en therapeutique | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| DE602006014022D1 (de) | 5-substituierte indol-2-carbonsäureamidderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |